Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107 USD | -0.51% | -0.03% | -2.75% |
04:21pm | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Trading Ideas